Throughout our 60+ year history, our high-quality raw materials created through innovative fermentation and biotechnologies have contributed to the health, beauty and well-being of diverse populations around the globe.
In 1956, we pioneered as the world’s first manufacturer using fermentation for the production of the amino acid L-Glutamic Acid.
Since then, Kyowa has developed many industry-first technologies that continually improve ingredient performance while guaranteeing quality.
1949 Kyowa Hakko Kogyo Co., Ltd. established
1956 Invention of the L-Glutamic Acid production process by fermentation as the first industrial manufacturing process world-wide
1958 Invention of a process for manufacturing L-Lysine by fermentation
1969 Overseas Sales Office Kyowa Hakko U.S.A., Inc. established
1973 Overseas Sales Office Kyowa Hakko Europe GmbH established
1982 Kyowa Italiana Farmaceutici S.r.l. established
1993 Started manufacturing the nucleic acid related compound Citicoline using fermentation
1997 Started manufacturing L-Hydroxyproline after establishing a new manufacturing method
2000 Developed mass production technology for manufacturing sugar chains using fermentation
2004 Started manufacturing Ornithin health food product line
2005 Started manufacturing L-Alanyl-L-Glutamine using fermentation
2007 Kyowa Hakko Kogyo Co., Ltd. acquired Daiichi Fine Chemical Co., Ltd.
2007 Strategic alliance between Kyowa Hakko Group and Kirin Group
2008 Kyowa Hakko Kirin Co., Ltd. established
2008 Kyowa Hakko Bio Co., Ltd. established, taking over the Bio-Chemical business from the Kyowa Hakko Group and Kirin Group alliance.
2010 Kyowa Hakko Bio Italia S.r.l. established as wholly owned subsidiary of Kyowa Hakko Europe GmbH
2015 Daiichi Fine Chemical Co., Ltd. changed its name to Kyowa Pharma Chemical Co., Ltd.